State Street’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

State Street’s Portfolio IMPL Stock Details IMPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,200	Closed	-$10.8K	–	4527
2023 Q3	$10.8K	Hold	25,200	–	–	﹤0.01%	4503
2023 Q2	$32K	Hold	25,200	–	–	﹤0.01%	4526
2023 Q1	$35.3K	Sell	25,200 -12,300	-33%	-$29.4K	﹤0.01%	4592
2022 Q4	$141K	Sell	37,500 -4,200	-10%	-$15.3K	﹤0.01%	4248
2022 Q3	$203K	Hold	41,700	–	–	﹤0.01%	4139
2022 Q2	$389K	Sell	41,700 -138,345	-77%	-$1.01M	﹤0.01%	3940
2022 Q1	$1.15M	Buy	180,045 +11,107	+7%	+$84K	﹤0.01%	3766
2021 Q4	$1.46M	Buy	168,938 +39,964	+31%	+$399K	﹤0.01%	3728
2021 Q3	$1.57M	Buy	128,974 +82,676	+179%	+$1.2M	﹤0.01%	3673
2021 Q2	$410K	Buy	+46,298	New	+$553K	﹤0.01%	3935

Other funds holding IMPL

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

State Street's IMPL Position: Q4 2023 in Review

State Street sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 25,200 shares — an estimated $10.8K sold.

State Street first reported a position in IMPL in Q2 2021 and held it in 10 quarters. The position peaked at $1.57M in Q3 2021. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

State Street reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State Street sold 25,200 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $10.8K.
State Street first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2021 and held it in 10 quarters.
State Street's Impel Pharmaceuticals Inc. Common Stock position peaked at $1.57M in Q3 2021.
2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.